Dopamine transporter levels in cocaine dependent subjects

Drug and Alcohol Dependence

Volumn 98, Issue 1-2, 2008, Pages 70-76

  Crits Christoph, Paul ^a   Newberg, Andrew ^b   Wintering, Nancy ^b   Ploessl, Karl ^b   Gibbons, Mary Beth Connolly ^a   Ring Kurtz, Sarah ^a   Gallop, Robert ^c   Present, Julie ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^c WEST CHESTER UNIVERSITY   (United States)

Author keywords

Cocaine dependence; Dopamine transporter; SPECT

Indexed keywords

DIAGNOSTIC AGENT; DOPAMINE TRANSPORTER; TECHNETIUM COMPLEX; TECHNETIUM TC 99M TRODAT 1; TECHNETIUM TC 99M TRODAT-1; TROPANE DERIVATIVE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BASAL GANGLION; CAUDATE NUCLEUS; COCAINE DEPENDENCE; DRUG EFFECT; FEMALE; HEMISPHERIC DOMINANCE; HUMAN; MALE; METABOLISM; MIDDLE AGED; PHYSIOLOGY; PUTAMEN; REFERENCE VALUE; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

ADULT; BASAL GANGLIA; CAUDATE NUCLEUS; COCAINE-RELATED DISORDERS; DOMINANCE, CEREBRAL; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; FEMALE; HUMANS; MALE; MIDDLE AGED; ORGANOTECHNETIUM COMPOUNDS; PUTAMEN; REFERENCE VALUES; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 58749097655     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2008.04.014     Document Type: Article

References (41)

1. [99mTc]TRODAT-1 binding to dopamine transporters in nonhuman primates using single-photon emission tomography. Eur. J. Nucl. Med. 1999, 26:518-526.
2. 99mTc]TRODAT-1 and single photon emission tomography. Eur. J. Nucl. Med. 2000, 27:1714-1718.
3. Amsterdam J.D., Newberg A.B. A preliminary study of dopamine transporter binding in bipolar and unipolar depressed patients and healthy controls. Neuropsychobiology 2007, 55:167-170.
4. Budygin E.A., Phillips P.E., Wightman R.M., Jones S.R. Terminal effects of ethanol on dopamine dynamics in rat nucleus accumbens: an in vitro voltammetric study. Synapse 2001, 42:77-79.
5. Carroll M.R., Rodd Z.A., Murphy J.M., Simon J.R. Chronic ethanol consumption increases dopamine uptake in the nucleus accumbens of high alcohol drinking rats. Alcohol 2006, 40:103-109.
6. Chang L.T. A method for attenuation correction in radionuclide computed tomography. IEEE Trans. Nucl. Sci. 1978, 25:638-643.
7. Chen N., Reith M.E. Structure and function of the dopamine transporter. Eur. J. Pharmacol. 2000, 405:329-339.
8. Dackis C.A., Gold M.S. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci. Biobeh. Rev. 1985, 9:469-477.
9. Daws L.C., Callaghan P.D., Moron J.A., Kahlig K.M., Shippenberg T.S., Javitch J.A., Galli A. Cocaine increases dopamine uptake and cell surface expression of dopamine transporters. Biochem. Bioph. Res. Co. 2002, 290:1545-1550.
10. Di Chiara G., Imperato A. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc. Nat. Acad. Sci. U.S.A. 1988, 85:5274-5278.
11. Egilmez Y., Jung M.E., Lane J.D., Emmett-Oglesby M.W. Dopamine release during cocaine self-administration in rats: effect of SCH23390. Brain Res. 1995, 701:142-150.
12. First M.B., Spitzer R.L., Gibbon M., Williams B.W. Structured Clinical Interview for Axis I DSM-IV Disorders--Patient Edition 1994, American Psychiatric Press, Washington D.C.
13. Gorelick D.A., Kim Y.K., Bencherif B., Boyd S.J., Nelson R., Copersino M., Endres C.J., Dannals R.F., Frost J.J. Imaging brain mu-opioid receptors in abstinent cocaine users: time course and relation to cocaine craving. Bio. Psychiatry 2005, 57:1573-1582.
14. Ho M., Segre M. Individual and combined effects of ethanol and cocaine on the human dopamine transporter in neuronal cell lines. Neurosci. Lett. 2001, 299:229-233.
15. Izenwasser S., Cox B.M. Daily cocaine treatment produces a persistent reduction in [3H]dopamine uptake in vitro in rate nucleus accumbens but not in striatum. Brain Res. 1990, 531:338-341.
16. Jacobsen L.K., Staley J.K., Malison R.T., Zoghbi S.S., Seibyl J.P., Kosten T.R., Innis R.B. Elevated central serotonin transporter binding availability in acutely abstinent cocaine-dependent patients. Am. J. Psychiatry 2000, 157:1134-1140.
17. Kimmel H.L., Carroll F.I., Kuhar M.J. RTI-76, an irreversible inhibitor of dopamine transporter binding, increases locomotor activity in the rat at high doses. Brain Res. 2001, 897:157-163.
18. Krause K.H., Dresel S.H., Krause J., Kung H.F., Tatsch K., Ackenheil M. Stimulant-like action of nicotine on striatal dopamine transporter in the brain of adults with attention deficit hyperactivity disorder. Int. J. Neuropsychopharmacol. 2002, 5:111-113.
19. Kuhar M.J., Pilotte N.S. Neurochemical changes in cocaine withdrawal. Trends Pharmacol. Sci. 1996, 17:260-264.
20. 99mTc]TRODAT-1: a dopamine transporter imaging agent. J. Nuclear. Med. 1999, 40:150-158.
21. Letchworth S.R., Nader M.A., Smith H.R., Friedman D.P., Porrino L.J. Progression of changes in dopamine transporter binding site density as a result of cocaine self-administration in rhesus monkeys. J. Neurosci. 2001, 21:2799-2807.
22. Little K.Y., Elmer L.W., Zhong H., Zhang L. Cocaine induction of dopamine transporter trafficking to the plasma membrane. Mol. Pharmacol. 2002, 61:436-445.
23. Little K.Y., Kirkman J.A., Carroll F.I., Clark T.C., Duncan G.E. Cocaine use increases [3H]WIN 35428 binding sites in human striatum. Brain Res. 1993, 628:17-25.
24. Little K.Y., Zhang L., Desmond T., Frey K.A., Dalack G.W., Cassin B.J. Striatal dopaminergic abnormalities in human cocaine users. Am. J. Psychiatry 1999, 156:238-245.
25. Madras B.K., Kaufman M.J. Cocaine accumulates in dopamine-rich regions of primate brain after i.v. administration: comparison with mazindol distribution. Synapse 1994, 18:261-275.
26. Mash D.C., Pablo J., Ouyang Q., Hearn W.L., Izenwasser S. Dopamine transport function is elevated in cocaine users. J. Neurochem. 2002, 81:292-300.
27. 123I] beta-CIT SPECT. Am. J. Psychiatry 1998, 155:832-834.
28. McLellan A.T., Kushner H., Metzger D., Peters R., Smith I., Grissom, Pettinati H., Argeriou M. The fifth edition of the Addiction Severity Index. J. Subst. Abuse 1992, 9:199-213.
29. Newberg A., Lerman C., Wintering N., Ploessl K., Mozley P.D. Dopamine transporter binding in smokers and nonsmokers. Clin. Nucl. Med. 2007, 32:452-455.
30. Ritz M.C., Lamb R.J., Goldberg S.R., Kuhar M.J. Cocaine receptors on dopamine transporters are related to self-administration of cocaine. Science 1987, 237:1219-1223.
31. Sharpe L.G., Pilotte N.S., Mitchell W.M., De Souza E.B. Withdrawal of repeated cocaine decreases autoradiographic [3H]mazindol-labelling of dopamine transporter in rat nucleus accumbens. Eur. J. Pharmacol. 1991, 203:141-144.
32. Staley J.K., Hearn W.L., Ruttenber A.J., Wetli C.V., Mash D.C. High affinity cocaine recognition sites on the dopamine transporter are elevated in fatal cocaine overdose victims. J. Pharmacol. Exp. Ther. 1994, 271:1678-1685.
33. 99mTc]TRODAT-1 SPECT binding to dopamine transporters in patients with multiple system atrophy and Parkinson's disease. Eur. J. Nucl. Med. Mol. Imaging 2005, 32:302-307.
34. Tupala E., Kuikka J.T., Hall H., Bergstrom K., Sarkioja T., Rasanen P., Mantere T., Hiltunen J., Vepsalainen J., Tiihonen J. Measurement of the striatal dopamine transporter density and heterogeneity in type 1 alcoholics using human whole hemisphere autoradiography. Neuroimage 2001, 14:87-94.
35. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., Dewey S.L., Wolf A.P. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14:169-177.
36. Volkow N.D., Wang G.J., Fischman M.W., Foltin R.W., Fowler J.S., Abumrad N.N., Vitkun S., Logan J., Gatley S.J., Pappas N., Hitzemann R., Shea C.E. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997, 386:827-830.
37. Volkow N.D., Wang G.J., Fowler J.S., Logan J., Hitzemann R., Gatley S.J., MacGregor R.R., Wolf A.P. Cocaine uptake is decreased in the brain of detoxified cocaine abusers. Neuropsychopharmacology 1996, 14:159-168.
38. Weiss R.D., Griffin M.L., Hufford C., Muenz L.R., Najavits L.M., Jansson S.B., Kogan J., Thompson H.J. Early prediction of initiation of abstinence from cocaine: use of a craving questionnaire. Am. J. Addict. 1997, 6:224-231.
39. Weiss R.D., Griffin M.L., Mazurick C., Berkman B., Gastfriend D.R., Frank A., Barber J.P., Blaine J., Salloum I., Moras K. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am. J. Psychiatry 2003, 160:1320-1325.
40. Wilson J.M., Levey A.I., Bergeron C., Kalasinsky K., Ang L., Peretti F., Adams V.I., Smialek J., Anderson W.R., Shannak K., Deck J., Niznik H.B., Kish S.J. Striatal dopamine, dopamine transporter, and vesicular monoamine transporter in chronic cocaine users. Ann. Neurol. 1996, 40:428-439.
41. Zubieta J.K., Gorelick D.A., Stauffer R., Ravert H.T., Dannals R.F., Frost J.J. Increased mu opioid receptor binding detected by PET in cocaine-dependent men is associated with cocaine craving. Nat. Med. 1996, 2:1225-1229.